Modifications of the innate immune system in atopic dermatitis

Journal of Innate Immunity

Volumn 3, Issue 2, 2011, Pages 131-141

  Maintz, Laura ^a   Novak, Natalija ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Allergy; Antimicrobial peptides; Pathogen associated molecular patterns; Toll like receptor

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; THYMIC STROMAL LYMPHOPOIETIN;

APOPTOSIS; ATOPIC DERMATITIS; GAMMA DELTA T LYMPHOCYTE; GENE MUTATION; HUMAN; INNATE IMMUNITY; LEUKOCYTE; NATURAL KILLER CELL; PLASMACYTOID DENDRITIC CELL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; TH2 CELL;

ANTIMICROBIAL CATIONIC PEPTIDES; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; SKIN DISEASES, INFECTIOUS;

EID: 79952006098     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000323963     Document Type: Review

References (51)

1. Hon KL, Wong KY, Leung TF, Chow CM, Ng PC: Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol 2008; 9: 45-50.
2. Candi E, Schmidt R, Melino G: The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-340. (Pubitemid 40516899)
3. Jensen JM, Folster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, et al: Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122: 1423-1431. (Pubitemid 38757224)
4. Rodriguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown SJ, Cordell HJ, et al: Metaanalysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009; 123: 1361-1370.
5. de Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA: Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009; 129: 14-30.
6. Oyoshi MK, Murphy GF, Geha RS: Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009; 124: 485-493, 493e1.
7. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, de Benedetto A, et al: Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120: 150-155. (Pubitemid 46990506)
8. Kim BE, Leung DY, Boguniewicz M, Howell MD: Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008; 126: 332-337.
9. Hatano Y, Terashi H, Arakawa S, Katagiri K: Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J Invest Dermatol 2005; 124: 786-792. (Pubitemid 40489506)
10. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, et al: The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004; 113: 565-567. (Pubitemid 38338967)
11. Oh DY, Schumann RR, Hamann L, Neumann K, Worm M, Heine G: Association of the Toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis. Allergy 2009; 64: 1608-1615.
12. Weidinger S, Novak N, Klopp N, Baurecht H, Wagenpfeil S, Rümmler L, et al: Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema. J Allergy Clin Immunol 2006; 118: 277-279. (Pubitemid 43946482)
13. Terhorst D, Kalali BN, Weidinger S, Illig T, Novak N, Ring J, et al: Monocyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to Toll-like receptor ligands. Clin Exp Allergy 2007; 37: 381-390. (Pubitemid 46393237)
14. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, et al: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003; 171: 3262-3269. (Pubitemid 37093553)
15. Niebuhr M, Lutat C, Sigel S, Werfel T: Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis. Allergy 2009; 64: 1580-1587.
16. Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S, et al: The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 2008; 121: 1013-1019.
17. Novak N, Yu CF, Bussmann C, Maintz L, Peng WM, Hart J, et al: Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 2007; 62: 766-772.
18. Beygo J, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S: No evidence of an association between polymorphisms in the IRAK-M gene and atopic dermatitis in a German cohort. Mol Cell Probes 2009; 23: 16-19.
19. Weidinger S, Klopp N, Rümmler L, Wagenpfeil S, Novak N, Baurecht HJ, et al: Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 2005; 116: 177-184.
20. Macaluso F, Nothnagel M, Parwez Q, Petrasch-Parwez E, Bechara FG, Epplen JT, et al: Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis. Exp Dermatol 2007; 16: 692-698.
21. Kabesch M, Peters W, Carr D, Leupold W, Weiland SK, von Mutius E: Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J Allergy Clin Immunol 2003; 111: 813-817. (Pubitemid 36470254)
22. Weidinger S, Klopp N, Rümmler L, Wagenpfeil S, Baurecht HJ, Gauger A, et al: Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin Exp Allergy 2005; 35: 866-872.
23. Carrera MC, Moura P, Crovella S, de Souza PR, de Alencar LC, Sarinho E: High polymorphism of the MBL2 gene in patients with atopic dermatitis. Ann Allergy Asthma Immunol 2010; 105: 39-42.
24. Hashimoto S, Nakamura K, Oyama N, Kaneko F, Fujita T, Tsunemi Y, et al: Mannose-binding lectin (MBL) single nucleotide polymorphism is not associated with atopic dermatitis in Japanese patients. J Dermatol 2005; 32: 1038-1040. (Pubitemid 43258834)
25. Howell MD: The role of human beta defensins and cathelicidins in atopic dermatitis. Curr Opin Allergy Clin Immunol 2007; 7: 413-417.
26. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-1160.
27. Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, et al: Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010; 130: 1355-1364.
28. Kisich KO, Carspecken CW, Fieve S, Boguniewicz M, Leung DY: Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol 2008; 122: 62-68.
29. Eyerich K, Pennino D, Scarponi C, Foerster S, Nasorri F, Behrendt H, et al: IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 2009; 123: 59-66.
30. Peng WM, Jenneck C, Bussmann C, Bogdanow M, Hart J, Leung DY, et al: Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol 2007; 127: 1261-1263. (Pubitemid 46625135)
31. Buchau AS, MacLeod DT, Morizane S, Kotol PF, Hata T, Gallo RL: Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytes. J Invest Dermatol 2009; 129: 2148-2155.
32. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, et al: Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008; 122: 829-831.
33. Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, et al: Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 2005; 174: 8003-8010. (Pubitemid 40806311)
34. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G: Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002; 119: 433-439. (Pubitemid 35001954)
35. Sayama K, Komatsuzawa H, Yamasaki K, Shirakata Y, Hanakawa Y, Ouhara K, et al: New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of beta-defensins, LL37, and TLR2. Eur J Immunol 2005; 35: 1886-1895. (Pubitemid 40862337)
36. Bogiatzi SI, Fernandez I, Bichet JC, Marloie- Provost MA, Volpe E, Sastre X, et al: Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J Immunol 2007; 178: 3373-3377. (Pubitemid 46417601)
37. Wu WH, Park CO, Oh SH, Kim HJ, Kwon YS, Bae BG, et al: Thymic stromal lymphopoietin-activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis. J Allergy Clin Immunol 2010; 126: 290-299, 299e1-4.
38. He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS: TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc Natl Acad Sci USA 2008; 105: 11875-11880.
39. Homey B, Steinhoff M, Ruzicka T, Leung DY: Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006; 118: 178-189. (Pubitemid 43946487)
40. Ezzat MH, Sallam MA, Shaheen KY: Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity. Int J Dermatol 2009; 48: 822-829.
41. Gros E, Bussmann C, Bieber T, Förster I, Novak N: Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol 2009; 124: 753-760e1.
42. Strid J, Strobel S: Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy 2005; 4: 531-541. (Pubitemid 41448360)
43. Cho SH, Strickland I, Boguniewicz M, Leung DY: Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001; 108: 269-274.
44. Matsubara M, Harada D, Manabe H, Hasegawa K: Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. FEBS Lett 2004; 566: 195-200.
45. Langer K, Breuer K, Kapp A, Werfel T: Staphylococcus aureus -derived enterotoxins enhance house dust mite-induced patch test reactions in atopic dermatitis. Exp Dermatol 2007; 16: 124-129.
46. Bieber T: Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
47. Breuer K, Wittmann M, Kempe K, Kapp A, Mai U, Dittrich-Breiholz O, et al: Alpha-Toxin is produced by skin-colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy 2005; 35: 1088-1095.
48. Katsuta M, Takigawa Y, Kimishima M, Inaoka M, Takahashi R, Shiohara T: NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 2006; 176: 7736-7744. (Pubitemid 43849074)
49. Novak N, Allam JP, Hagemann T, Jenneck C, Laffer S, Valenta R, et al: Characterization of FcεRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2004; 114: 364-370. (Pubitemid 39119038)
50. Wollenberg A, Wagner M, Gunther S, Towarowski A, Tuma E, Moderer M, et al: Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002; 119: 1096-1102. (Pubitemid 35434173)
51. Novak N: New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy 2009; 64: 265-275.